TY - JOUR
T1 - Homo sapiens versus SARS-CoV-2
AU - Siddiqui, Ruqaiyyah
AU - Khan, Naveed Ahmed
PY - 2020/8/19
Y1 - 2020/8/19
N2 - The current outbreak has led to renewed interest in developing novel disinfectants/drugs to kill “a species” for the benefit of “another species.” While the discovery of new antimicrobials will ensure our ability to counter such threats in the short term, the development of drug resistance through natural selection will lead to the evolution of more “superbugs.” In this regard, there is a need to understand viral perspective and associated molecular mechanisms and whether we can regulate viral strategies for our benefit to coexist in the long term.
AB - The current outbreak has led to renewed interest in developing novel disinfectants/drugs to kill “a species” for the benefit of “another species.” While the discovery of new antimicrobials will ensure our ability to counter such threats in the short term, the development of drug resistance through natural selection will lead to the evolution of more “superbugs.” In this regard, there is a need to understand viral perspective and associated molecular mechanisms and whether we can regulate viral strategies for our benefit to coexist in the long term.
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-85089481353&partnerID=MN8TOARS
U2 - 10.1021/acschemneuro.0c00436
DO - 10.1021/acschemneuro.0c00436
M3 - Article
SN - 1948-7193
VL - 11
SP - 2391
EP - 2392
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 16
ER -